Author: Vitaliy Dadalyan

Nasdaq Whale Emerges as Facebook, Amazon See Option Trades

(Bloomberg) -- Tens of millions of dollars in options trades linked to the biggest American technology companies have again surfaced in U.S. markets, weeks after the Japanese conglomerate SoftBank Group Corp. was linked to similar wagers.Amazon.com Inc., Facebook Inc. and Netflix Inc. were among companies that saw block trades of call contracts Thursday, representing speculation on movements in their shares through the first months of next year. Call options are bullish bets by themselves but can also be paired with other positions as part of a hedge.The identity of the buyer wasn’t known. Analysts noted a resemblance to a series of wagers made by SoftBank over the summer, which entailed billions of dollars of call purchases in tech stocks. Those “Nasdaq whale” wagers -- combined with an explosion in buying by individuals and day traders in short-dated options -- were theorized by some analysts to have created a bullish feedback loop...

Is Gold’s Rally Over?

Gold’s reversal from all-time highs … the factors behind recent weakness … why Eric Fry sees big gains returning for the yellow metal First, an apology … Yesterday, we planned to publish the Digest at 2 p.m. ET. In it was a reminder to join Louis Navellier for his Moneyball Multiplier Challenge event at 4 p.m. ET.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Unfortunately, due to a technical outage, the Digest published beyond its intended time. Given this, readers might have felt puzzled seeing a reminder to join an event that had already taken place. If you were among that group, apologies for the confusion. But the good news is you can watch a replay of the entire event by clicking here. If you’re looking to shore up your retirement finances, or simply grow your nest egg, tune in to learn how Louis’ “quant” strategy can help. Now, onto today’s Digest … ***So, what happened to gold? After setting a record-high in early August,...

Risk aversion sets in after Trump tests positive for coronavirus

A wave of risk aversion swept markets on Friday after U.S. President Donald Trump said he and his wife had tested positive for COVID-19 and will isolate, weeks ahead of the elections. Shortly before 0500 GMT, Trump said on Twitter that he and his wife had been tested for coronavirus after Hope Hicks, a senior advisor who recently traveled with the president, tested positive. U.S. stock futures fell on the news and Treasury yields dipped....

Stocks slide after Trump diagnosed with coronavirus

Stocks sold off and investors quit riskier assets on Friday after U.S. President Donald Trump said he and his wife had tested positive for the coronavirus and would isolate, four weeks before U.S. elections. U.S. stock futures fell and European shares opened lower, although they recovered some losses in early London trading after the initial overnight move. Shortly before 0500 GMT, Trump said on Twitter that he and his wife had been tested for coronavirus after Hope Hicks, a senior advisor who recently traveled with the president, tested positive....

Whale Resurfaces as Facebook, Amazon See Big Options Trades

(Bloomberg) -- Trades in which tens of millions of dollars were spent betting on the biggest American technology companies have again surfaced in the options market, weeks after the Japanese conglomerate SoftBank Group Corp. was linked to similar wagers.Amazon.com Inc., Facebook Inc. and Netflix Inc. were among companies that saw block trades of call contracts Thursday, representing speculation on movements in their shares through the first months of next year. Call options are bullish bets by themselves but can also be paired with other positions as part of a hedge.The identity of the buyer wasn’t known. Analysts noted a resemblance to a series of wagers made by SoftBank over the summer, which entailed billions of dollars of call purchases in tech stocks. Those “Nasdaq whale” wagers -- combined with an explosion in buying by individuals and day traders in short-dated options -- were theorized by some analysts to have created a...

CTI BioPharma (CTIC) Stock Could Hit $6, Says Analyst

Until yesterday, shares of CTI BioPharma (CTIC) had been firmly planted in the red in 2020. But sentiment can turn fast in the biotech world and the cancer drug maker provided investors with a dreamy week. The stock surged 135% over the past two trading sessions, after the FDA cleared the way for one of its treatment’s quick approval.Specifically, the company announced that after a pre-NDA meeting with the FDA, the agency has granted the biotech a rolling NDA submission for possible accelerated approval of pacritinib in thrombocytopenic myelofibrosis patients. The NDA submission should be completed by 1Q21.CTI managed to persuade the regulators that based on the existing data, the risk mitigation measures have shifted the risk/benefit profile enough to allow for a review. Results from the Phase III PERSIST-1 and 2 and the dose-finding PAC203 study have been deemed strong enough for NDA submission.Needham analyst Chad Messer believes “the surprising...